{
  "meta": {
    "timestamp": "2025-01-06T14:03:53.773749",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Clearpoint Neuro ",
      "symbol": "CLPT ",
      "analysis": {
        "historical": {
          "risk_score": 60,
          "key_risks": [
            "Regulatory Hurdles: Delays in obtaining regulatory approvals for new indications and markets could impact revenue growth and market expansion.",
            "Market Competition: Highly competitive landscape with larger medical device firms offering alternative solutions, potentially limiting market share and pricing power.",
            "Financial Sustainability: Heavy reliance on external funding and partnerships makes the company vulnerable to market fluctuations and investor sentiment.",
            "Adoption Barriers: High cost and specialized nature of systems may limit widespread adoption, particularly in regions with constrained healthcare budgets."
          ],
          "controversies": [
            "Shareholder Investigation: Purcell & Lefkowitz LLP has announced a shareholder investigation into Clearpoint Neuro, raising concerns about potential governance or financial issues."
          ],
          "environmental_issues": [],
          "social_issues": [],
          "governance_issues": [
            "Shareholder Investigation: Potential governance or financial issues under investigation by Purcell & Lefkowitz LLP."
          ],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": " January 12, 2024 ClearPoint Neuro, Inc. Brennan Sullivan Regulatory ...",
              "snippet": "U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.06.07 Silver Spring, MD 20993 www.fda.gov January 12, 2024 ClearPoint Neuro, Inc. Brennan Sullivan Regulatory Affairs Manager 120 S. Sierra Avenue, Suite 100 Solana Beach, California 92075 Re: K233141 Trade/Device Name: SmartFrame OR",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:27.210356+00:00",
              "published_date": null,
              "source_hash": "6f2891a2759be6de7b58c2feab8e133a"
            },
            {
              "url": "",
              "title": " November 13, 2024 ClearPoint Neuro, Inc. Brennan Sullivan Regulatory ...",
              "snippet": "U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.07.04 Silver Spring, MD 20993 www.fda.gov November 13, 2024 ClearPoint Neuro, Inc. Brennan Sullivan Regulatory Affairs 120 S. Sierra Avenue, Suite 100 Solana Beach, California 92075 Re: DEN240023 Trade/Device Name: SmartFlow Neuro Cannula",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:27.210469+00:00",
              "published_date": null,
              "source_hash": "fb69ea01e24bffd54e7d9f1a1ff3f536"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro Announces FDA De Novo Marketing Authorization of ...",
              "snippet": "SOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the \"Company\"), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the SmartFlow Neuro Cannula using the De Novo ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:27.210484+00:00",
              "published_date": null,
              "source_hash": "e2a7548e71ba95a8b60baa7c1ab8ec90"
            },
            {
              "url": "",
              "title": " November 27, 2023 ClearPoint Neuro Inc. Brennan Sullivan Regulatory ...",
              "snippet": "U.S. Food & Drug Administration 10903 New Hampshire Avenue Doc ID# 04017.06.05 Silver Spring, MD 20993 www.fda.gov November 27, 2023 ClearPoint Neuro Inc. Brennan Sullivan Regulatory Affairs Manager 120 S. Sierra Avenue, Suite 100 Solana Beach, California 92075 Re: K233243",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:27.210496+00:00",
              "published_date": null,
              "source_hash": "34c1b005963183b6e7952edaa3f3755b"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases ...",
              "snippet": "Clinical Validation of the Brain Model Published Online in the Journal NeuroImage. SOLANA BEACH, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \"Company\"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced FDA Clearance and first-in-human cases using the ClearPoint 2.2 Software ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:27.210507+00:00",
              "published_date": null,
              "source_hash": "140410b1883dcc747d76de587369e37e"
            },
            {
              "url": "",
              "title": "FDA Clears Stereotactic System for Neurologic ... - Practical Neurology",
              "snippet": "The Food and Drug Administration (FDA) has granted 510(k) clearance to the SmartFrame OR Stereotactic System (ClearPoint Neuro, Solana Beach, CA), which consists of the SmartFrame OR, a system that assists in the placement of instruments or devices during neurologic, stereotactic surgeries and procedures, and the ClearPointer Optical Navigation Wand.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.243140+00:00",
              "published_date": null,
              "source_hash": "18805927818e6a9dfe17bcb8113c0007"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro Announces FDA De Novo Marketing Authorization of ...",
              "snippet": "Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United States SOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:27.210528+00:00",
              "published_date": null,
              "source_hash": "a7425ddcb1bca0b81e1526ac08c501b2"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro Announces FDA Clearance for SmartFrame OR ...",
              "snippet": "Limited Market Release of First Purpose-Built OR Product to Begin in First Half of 2024. SOLANA BEACH, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the \"Company\"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has received 510(k) clearance for its SmartFrame OR ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:27.210539+00:00",
              "published_date": null,
              "source_hash": "6bb49374dfd0daa559e7811590ee2f79"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro Announces FDA Clearance for SmartFrame OR ...",
              "snippet": "ClearPoint Neuro Announces FDA Clearance for SmartFrame OR\u2122 Stereotactic System. ClearPoint Neuro, Inc. Tue, Jan 16, 2024, 8:00 AM 5 min read. In This Article: CLPT . ClearPoint Neuro, Inc.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:27.210550+00:00",
              "published_date": null,
              "source_hash": "8771480fddb753428b6c77723c4d5dff"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro Announces FDA De Novo Marketing Authorization of ...",
              "snippet": "ClearPoint Neuro, Inc., a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the U.S. Food and Drug Administration has granted marketing ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:27.210564+00:00",
              "published_date": null,
              "source_hash": "d0fc16406af429b21e42a28f0058ba34"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR System",
              "snippet": "ClearPoint Neuro, Inc. CLPT recently announced its receipt of the FDA's 510(k ... release in the second half of 2024. The latest regulatory approval is likely to significantly boost ClearPoint ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:29.735850+00:00",
              "published_date": "2024-01-17T21:25:00+00:00",
              "source_hash": "6f6e0f5810b5c007c823976e4b310f76"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro announces SmartFlow Neuro Cannula FDA authorization",
              "snippet": "ClearPoint Neuro (CLPT) \"announced the U.S. Food and Drug Administration has granted marketing authorization for the SmartFlow Neuro Cannula using the De Novo pathway. The SmartFlow Neuro ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:39.699224+00:00",
              "published_date": "2024-11-13T23:35:00+00:00",
              "source_hash": "0bece0c0e96645a58bd409eb65a37130"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain",
              "snippet": "This signifies the first-ever FDA ... regulatory bodies in both the U.S. and EU for delivery of an approved gene therapy to the brain. The industry-leading cannula is used by many of ClearPoint ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:29.735949+00:00",
              "published_date": "2024-11-13T23:15:00+00:00",
              "source_hash": "ead6e8c2bd7b3b2af895d55d91c50adb"
            },
            {
              "url": "",
              "title": "ClearPoint: Fundamentals Continue To Improve",
              "snippet": "ClearPoint's laser ... is targeting patients with neurological disorders like paralysis, ALS, blindness and hearing loss. The company's Utah Array is currently FDA-cleared for temporary monitoring ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro regulatory challenges FDA",
              "retrieved_at": "2025-01-06T21:03:29.735961+00:00",
              "published_date": "2024-12-09T08:50:00+00:00",
              "source_hash": "4e139831c812114951c53186568be198"
            },
            {
              "url": "",
              "title": "Clearpoint Neuro",
              "snippet": "Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:39.699107+00:00",
              "published_date": "2024-12-24T18:00:00+00:00",
              "source_hash": "c17924cce2a041fcb28327ed70228529"
            },
            {
              "url": "",
              "title": "Purcell & Lefkowitz LLP Announces Shareholder Investigation of ...",
              "snippet": "ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company\u00e2 s flagship product is the ClearPoint Neuro Navigation System.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:31.202690+00:00",
              "published_date": null,
              "source_hash": "51b446aa24adb21e8449e81ade817102"
            },
            {
              "url": "",
              "title": "SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder ...",
              "snippet": "NEW YORK, May 2, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ClearPoint Neuro, Inc. (NASDAQ: CLPT) on behalf of the company's shareholders. The investigation ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:31.202829+00:00",
              "published_date": null,
              "source_hash": "42882a1411b177bfe7fe9db1b376ebc3"
            },
            {
              "url": "",
              "title": " January 12, 2024 ClearPoint Neuro, Inc. Brennan Sullivan Regulatory ...",
              "snippet": "ClearPoint Neuro, Inc. 6349 Paseo Del Lago Carlsbad, CA 92011 Correspondent Contact Information: Brennan Sullivan 120 S. Sierra Ave. Solana Beach, CA 92075 . 617-678-1028. bsullivan@clearpointneuro.com Device Common Name: Neurological Stereotactic Instrument Device Regulation & Name: Neurological Stereotaxic Instrument, 21CFR 882.4560",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.242768+00:00",
              "published_date": null,
              "source_hash": "8492e3d571a082f6e8c3840705843b90"
            },
            {
              "url": "",
              "title": " CLEARPOINT NEURO, INC. - AnnualReports.com",
              "snippet": "CLEARPOINT NEURO, INC. (Exact name of registrant as specified in its charter) Delaware 58-2394628 (State or other jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 5 Musick 92618 Irvine, California (Zip Code) (Address of principal executive offices) (949) 900-6833 (Registrant's telephone number, including ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:31.202865+00:00",
              "published_date": null,
              "source_hash": "f39caf1a7943623bd61ba17be3015428"
            },
            {
              "url": "",
              "title": " September 16, 2022 ClearPoint Neuro, Inc. \u2105 John Smith Partner Hogan ...",
              "snippet": ": ClearPoint Neuro, Inc. ClearPoint System (K181195) 5. Device Description. The ClearPoint System is essentially identical from a technological standpoint to the cleared predicate . device described in K181195 (ClearPoint System). The company has made updates that are limited . to the software of the ClearPoint System described in K181195 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:31.202877+00:00",
              "published_date": null,
              "source_hash": "a594f59e8133d962f3bcdc73b70c80be"
            },
            {
              "url": "",
              "title": "Ellisa Cholapranee - General Counsel - ClearPoint Neuro, Inc ... - LinkedIn",
              "snippet": "General Counsel at ClearPoint Neuro, Inc. \u00b7 Experience: ClearPoint Neuro, Inc. \u00b7 Location: San Diego \u00b7 500+ connections on LinkedIn. View Ellisa Cholapranee's profile on LinkedIn, a ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:31.202894+00:00",
              "published_date": null,
              "source_hash": "e419ce2ab7a672bd9a6e21f9a640a107"
            },
            {
              "url": "",
              "title": "How Does ClearPoint Neuro Work? - CBM",
              "snippet": "ClearPoint's Technological Innovation. ClearPoint Neuro is at the forefront of technological innovation in the field of neurosurgery. The company has developed a cutting-edge platform that combines advanced imaging, navigation, and robotic technologies to enable precise targeting and delivery of therapies for neurological disorders.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:31.202906+00:00",
              "published_date": null,
              "source_hash": "9b307e636f652b89cecdba059f601c83"
            },
            {
              "url": "",
              "title": "New ClearPoint Neuro software wins FDA clearance",
              "snippet": "The Company's flagship product, the ClearPoint Neuro Navigation System, has FDA clearance and CE mark. Filed Under: Business/Financial News , Health Technology , Imaging , Neurological ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:31.202917+00:00",
              "published_date": null,
              "source_hash": "81bc7a976aba3f2697ebc833ee250de9"
            },
            {
              "url": "",
              "title": "Corporate Governance :: ClearPoint Neuro, Inc. (CLPT)",
              "snippet": "Prior to joining ClearPoint Neuro, he served as Vice President and General Manager of Neuro Diagnostics and Therapy at Royal Philips, a publicly traded global health technology company, since March 2016. ... HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (Nasdaq: ACLS), a provider of equipment and service solutions for ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:31.202926+00:00",
              "published_date": null,
              "source_hash": "882910de03a58f573426e4ff843cb949"
            },
            {
              "url": "",
              "title": "Investor Relations :: ClearPoint Neuro, Inc. (CLPT)",
              "snippet": "ClearPoint Neuro is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. We uniquely provide both established clinical products as well as pre-clinical development services for controlled drug and device delivery. ... Outside Legal Counsel. Bass, Berry & Sims PLC 100 Peabody Place Suite 1300 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:31.202936+00:00",
              "published_date": null,
              "source_hash": "98acc33bd3cf1fcb4bb3ea12e0925189"
            },
            {
              "url": "",
              "title": "ClearPoint MR Focus Alters Brain Cases: Vanguards of Health Care",
              "snippet": "ClearPoint Neuro is changing brain surgery by developing a suite of new magnetic resonance (MR) navigation technologies that aid minimally invasive procedures and drug-delivery capabilities ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:39.699215+00:00",
              "published_date": "2024-11-04T00:00:00+00:00",
              "source_hash": "1119931d52ea47cedb9b1c628874881d"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro (CLPT) Gets FDA's Nod for SmartFrame OR System",
              "snippet": "ClearPoint Neuro, Inc. CLPT recently announced its receipt of the FDA's 510(k) clearance for its SmartFrame OR Stereotactic System. The system is expected to offer flexible workflows to surgeons ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:39.699190+00:00",
              "published_date": "2024-01-17T21:25:00+00:00",
              "source_hash": "fa851fbab09c2684d0a0e23b80168e6b"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro price target raised to $15 from $14 at B. Riley",
              "snippet": "B. Riley analyst Kyle Bauser raised the firm's price target on ClearPoint Neuro (CLPT) to $15 from $14 and keeps a Buy rating on the shares following the Q3 report. The firm sees continued ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro lawsuits legal disputes",
              "retrieved_at": "2025-01-06T21:03:34.065562+00:00",
              "published_date": "2024-11-08T07:46:00+00:00",
              "source_hash": "1ee226ac5b3e563e71b16e10ba170188"
            },
            {
              "url": "",
              "title": " State of California Comprehensive Compliance Program",
              "snippet": "As required by the California Health & Safety Code \u00a7119402(e), ClearPoint Neuro, Inc. hereby declares that, to the best of its knowledge, it is in all material respects in compliance with its Comprehensive Compliance Program and the relevant requirements of California Health & Safety Code \u00a7\u00a7 119400-119402. ClearPoint Neuro, Inc., January 1, 2025",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.242648+00:00",
              "published_date": null,
              "source_hash": "20a4aef0bfc1707df729dfe0447b91db"
            },
            {
              "url": "",
              "title": "MRI Interventions' ClearPoint System Enables Precise Delivery of ...",
              "snippet": "MRI Interventions' ClearPoint Neuro Intervention System is being used in the clinical trial to enable direct infusion of the gene therapy into an area of the brain affected by Parkinson's disease. ... The first patient was dosed on May 20 and there have been no safety issues. About MRI Interventions, Inc.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.242814+00:00",
              "published_date": null,
              "source_hash": "7d6d07eed8625bdc16990ae0cec957c9"
            },
            {
              "url": "",
              "title": " November 13, 2024 ClearPoint Neuro, Inc. Brennan Sullivan Regulatory ...",
              "snippet": "ClearPoint Neuro, Inc. Brennan Sullivan Regulatory Affairs 120 S. Sierra Avenue, Suite 100 ... Food and Drug Administration Safety and Innovation Act (FDASIA) on July 9, 2012. This law provides two ... The patient-contacting components of the device must be demonstrated to be biocompatible. (5) Performance data must demonstrate the sterility of ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.243073+00:00",
              "published_date": null,
              "source_hash": "7addb4da83268990717681d1d10c61ea"
            },
            {
              "url": "",
              "title": "ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame ...",
              "snippet": "Applications of the Company's current product portfolio include deep brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 60 active sites in the United States, Canada, and ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.243095+00:00",
              "published_date": null,
              "source_hash": "e72e311df9505225a8f13a9c03ce1e08"
            },
            {
              "url": "",
              "title": "Initial Clinical Experience With ClearPoint SmartFrame Array-Aided ...",
              "snippet": "Background: The ClearPoint SmartFrame Array (ClearPoint Neuro, Inc., Solana Beach, CA) system consists of a magnetic resonance imaging compatible frame supported by a customized neuro navigation software. This system received U.S. Food and Drug Administrationclearance for clinical use in January 2021. Our objective was to report initial safety data and user experience of SmartFrame Array ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.243126+00:00",
              "published_date": null,
              "source_hash": "19fd7a93ca604cb47ed18f7c5f7f425d"
            },
            {
              "url": "",
              "title": "How Does ClearPoint Neuro Work? - CBM",
              "snippet": "[cbm_blg_rlnkng]ClearPoint Neuro is a cutting-edge medical technology company that is revolutionizing the field of neurosurgery. By combining advanced imaging technology with precise navigation systems, ClearPoint Neuro allows surgeons to perform complex brain surgeries with unparalleled accuracy and safety. Their inno",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.243150+00:00",
              "published_date": null,
              "source_hash": "54bebd97454203ca5d422c3a59e00314"
            },
            {
              "url": "",
              "title": "ClearPoint Prism \u00ae Neuro Laser Therapy System",
              "snippet": "The ClearPoint Neuro Bibliography features ClearPoint in 90+ peer-reviewed publications. Read More The ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy under magnetic resonance imaging (MRI) guidance in medicine and surgery in neurosurgery ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.243160+00:00",
              "published_date": null,
              "source_hash": "084c93b5892e591e7ba4c21e8003da74"
            },
            {
              "url": "",
              "title": "NeuroVoices: Joe Burnett, on FDA Clearance of SmartFrame OR ...",
              "snippet": "As part of a new iteration of NeuroVoices, Joe Burnett, president and chief executive officer at ClearPoint Neuro, sat down to discuss the approval and what the SmartFrame system brings to neurology care. He spoke on how it can ease the workflow for neurosurgeons, the feasibility behind the product, and the patients who may be best suited for ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:37.243170+00:00",
              "published_date": null,
              "source_hash": "db31d6401304afd7ad1cdbdcffbf4e30"
            },
            {
              "url": "",
              "title": "ClearPoint: Fundamentals Continue To Improve",
              "snippet": "It was likely driven by Clinical Laserthermia's ongoing losses and limited access to capital, along with the growing demand for ClearPoint's Prism Neuro Laser ... the first patient in its ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Clearpoint Neuro  Clearpoint Neuro patient safety concerns",
              "retrieved_at": "2025-01-06T21:03:39.699205+00:00",
              "published_date": "2024-12-09T08:50:00+00:00",
              "source_hash": "da629b76e368d9fc341efa4fe714609b"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Clearpoint Neuro regulatory challenges FDA",
              "rationale": "Investigate potential delays or issues with FDA approvals for new indications or markets",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Clearpoint Neuro lawsuits legal disputes",
              "rationale": "Identify any ongoing or past legal disputes that could impact the company's operations or reputation",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Clearpoint Neuro patient safety concerns",
              "rationale": "Explore any reports or controversies related to patient safety or adverse outcomes linked to its products",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T14:03:53.773760",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}